Biomarkers Market Size, Share, Growth, Trends, Forecast 2021 to 2030

According to Report, the global biomarkers market is estimated to reach valuation US$ 150.59 billion by 2030 and is expected to grow at a CAGR of 16.2% during forecast period 2021 to 2030.

Growth Factors

 The increasing prevalence of chronic diseases, advancements in the techniques used for the development of biomarker-based diagnostics, and the growing geriatric population are the key factors projected to boost the market growth over the forecast period. The rising number of COVID-19 cases across the globe and an increasing number of researches on the use of biomarkers for facilitating the detection & treatment of COVID-19 will also support market growth. by increasing collaborations & funds for R&D activities, rising consumer awareness, COVID-19 pandemic, and technological advancements in disease diagnosis. Research aids in the development of effective therapies for the treatment of various diseases, such as cancer, Cardiovascular Diseases (CVDs), immunological diseases, and neurological diseases.

Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38602

Report Highlights

 The safety biomarkers segment held the largest market share of more than 40% in 2020, driven by the high awareness about routine health checkups, lowered drug attrition rate, and a rise in population that is at high risk of developing various diseases, such as cancer, cardiovascular conditions, and kidney disorders. The validation biomarkers segment is expected to exhibit the second-fastest growth over the forecast period owing to the use of these biomarkers in the pharmaceutical sector to predict the therapeutic failure of pharmaceutical molecules with low therapeutic profiles and distinct genetic profiles. 

The drug discovery & development segment dominated the biomarkers market in 2020 with a revenue share of more than 33.5% owing to extensive R&D initiatives for the development of targeted therapeutics, the ability to predict drug efficacy more easily, and a fast-track approval process. One such instance is the launch of targeted therapy for EGFR mutation in Non-small Cell Lung Cancer (NSCLC) patients by Halozyme, Inc.

The diagnostics segment is estimated to register the fastest CAGR over the forecast period owing to advantages in early-stage detection of disease, this creates an opportunity for the diagnostic segment to propel early diagnosis and improve the rate of diagnosis. 

The cancer segment held the largest market share of more than 37% in 2020, driven by a rise in demand for rapid and accurate diagnostic tools, an increase in global cancer burden, and an unmet need for more specific, personalized, therapeutic targets for cancer patients. Its use for early detection of cancer, estimate prognosis, and monitor response to the treatment is expected to drive the market.

North America accounted for the highest revenue share of more than 46% of the global market. The increasing disease burden, growing consumer awareness, proactive government actions, technological breakthroughs, and improvements in healthcare infrastructure can be attributed to this growth. For instance, in 2020, the Canadian Government-funded USD 79,000 research project for COVID-19 biomarkers.

Report Coverage

Key Players 

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Epigenetics AG
• General Electric
• Johnson & Johnson Services, Inc.
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers AG
• Qiagen

Market Segmentation

• Type
  • Safety
  • Efficacy
  • Validation
• Application
  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicines
  • Others
• Disease
  • Cancer
    • Safety
    • Efficacy
    • Validation
  • Cardiovascular Diseases
    • Safety
    • Efficacy
    • Validation
  • Neurological Diseases
    • Safety
    • Efficacy
    • Validation
  • Immunological Diseases
    • Safety
    • Efficacy
    • Validation
  • Others
    • Safety
    • Efficacy
    • Validation
• Regional 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38602

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333